NCT06060457 · Interventional trial
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
Overall registry status Completed
Phase 3
Conditions Respiratory Syncytial Virus
Delaware Valley sites
- DM Clinical Research - Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory